AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Veeva Systems: UBS Raises PT to $310 from $285, Keeps Neutral Rating
ByAinvest
Thursday, Aug 28, 2025 10:05 am ET1min read
Veeva Systems: UBS Raises PT to $310 from $285, Keeps Neutral Rating
Veeva Systems Inc. (VEEV) saw a significant update in its analyst ratings following its second-quarter (Q2) 2025 earnings report. UBS Group, one of the leading financial services providers, raised its price target (PT) for Veeva Systems from $285 to $310, while maintaining a neutral rating on the stock [1]. This move comes amidst a wave of positive analyst sentiment surrounding the life sciences software provider.Veeva Systems reported better-than-expected earnings for the second quarter, posting quarterly earnings of $1.99 per share, which exceeded the analyst consensus estimate of $1.90 per share. The company's quarterly sales totaled $789.081 million, beating the consensus estimate of $768.417 million [1]. These strong results have led several analysts to raise their price targets and maintain positive ratings on the stock.
Piper Sandler analyst Brent Bracelin maintained an Overweight rating and raised the price target from $325 to $355. Needham analyst Ryan MacDonald maintained a Buy rating and raised the price target from $300 to $355. Evercore ISI Group analyst Kirk Materne maintained an In-Line rating and raised the price target from $285 to $295. Truist Securities analyst Joe Meares maintained a Hold rating and raised the price target from $268 to $275. Stifel analyst David Grossman maintained a Buy rating and raised the price target from $295 to $320. BTIG analyst David Larsen maintained a Buy rating and raised the price target from $335 to $340. UBS analyst Karl Keirstead maintained a Neutral rating and raised the price target from $285 to $310 [1].
The company's CEO, Peter Gassner, expressed excitement about the company's performance, highlighting the transformational impact of Veeva AI and Veeva Data Cloud on the life sciences sector. Despite the positive earnings report and analyst sentiment, Veeva shares fell 5.5% to $277.31 on Thursday, following the announcement [1].
The recent earnings report and analyst ratings suggest that Veeva Systems is well-positioned to continue its growth trajectory in the life sciences software market. Investors should closely monitor the company's future financial performance and analyst ratings to make informed decisions.
References:
[1] https://www.benzinga.com/analyst-stock-ratings/price-target/25/08/47387036/veeva-systems-analysts-increase-their-forecasts-after-better-than-expected-q2-results
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet